Jan 11 (Reuters) - BrightPath Biotherapeutics Co Ltd :
* Says 6,500 units of its 12th series options were exercised to 650,000 shares of its common stock from Jan. 10 to Jan. 11
Source text in Japanese: goo.gl/vgWBcX
Further company coverage: (Beijing Headline News)
Our Standards: The Thomson Reuters Trust Principles.